Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Jersey for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Jersey only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Jersey (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Michael Colucciello (NPI 1215934146)

Field	Value
Entity Type	Individual
Organization	Michael Colucciello
Address	509 S Lenola Rd Ste 11a
City	Moorestown
State	NJ
ZIP	08057
Taxonomy	Ophthalmology Physician
NPI Enumerated	July 7, 2005

Payer Source	Total Paid
Medicare	$2.7M
Medicaid	$0

Key Findings

This provider is effectively a Medicare-only biller: lifetime Medicare revenue is $2.7M and there is no Medicaid billing on file. The NPI was enumerated on 2005-07-07 (~21 years ago), indicating long tenure in the market and an established billing history concentrated in Medicare.

Revenue is highly concentrated in a small set of intravitreal drug codes: J0178 accounts for $1.2M (45.1% of Medicare revenue), J2777 accounts for $791.7K (29.2%), and J2778 accounts for $230.7K (8.5%); the precomputed top-3 share is 82.7% of total Medicare revenue. This concentration shows most Medicare payments are driven by a few high-volume/high-cost ophthalmic drugs rather than broad service-line diversity.

The code mix and descriptions indicate an injection- and retina-focused ophthalmology practice: high counts for J0178 (1.8K claims), J2777 (27.3K claims), and J2778 (1.3K claims), together with a meaningful volume of 67028 (1.7K claims, $156.6K revenue) signal routine intravitreal pharmacologic therapy as the core service line. Complementary imaging codes such as 92134 (1.7K claims, $54.5K) support ongoing retina disease management and monitoring rather than a general primary ophthalmology clinic.

Competitive standing on drug administration is broadly typical rather than dominant: J0178 ranks #657 of 3204 providers (79th percentile; typical, unremarkable volume), J2777 ranks #340 of 2039 providers (83th percentile; typical, unremarkable volume), and J2778 ranks #349 of 1208 providers (71th percentile; typical, unremarkable volume). These ranks suggest the provider is a solid, above-average regional participant in intravitreal drug administration but not a national outlier or market leader for these codes.

Diagnostic imaging is a relative strength: 92134 ranks #1371 of 26868 providers (95th percentile; notably above typical national volume) with 1.7K claims and $54.5K in revenue, indicating this provider performs retinal imaging at a much higher rate than most peers and likely supports sustained follow-up and monitoring workflows. That elevated imaging footprint complements the high injectable drug volumes and points to integrated treatment-and-monitoring workflows for retinal disease.

Ancillary and unclassified drug codes appear but do not drive the practice: J3490 generated $101.6K (57 claims, $1783 avg paid/claim; 49th percentile; typical, unremarkable volume) and J3590 generated $31.8K (15 claims, $2120 avg paid/claim; 1th percentile; typical, unremarkable volume). These entries indicate occasional use of unclassified or biologic drugs in addition to the main retinal agents, but they remain secondary revenue contributors relative to the primary anti-VEGF/faricimab portfolio.

The provider’s office/ED evaluation-and-management billing is minimal relative to procedure revenue: 99214 shows 29 claims for $2.6K (0.1% of Medicare revenue) and 99215 shows 11 claims for $1.2K (0.0%). This pattern reinforces that the practice is procedure- and medication-driven (injections and imaging) rather than reliant on high-volume E/M office visits, which has implications for contracting and utilization review priorities for payers.

For payer strategy and network management, the combination of concentrated revenue in high-cost intravitreal drugs (notably J0178 and J2777) and a strong imaging footprint (92134 at the 95th percentile) means utilization and drug-pricing negotiation efforts should focus on injectable therapies and associated imaging follow-up. Given the absence of Medicaid billing, payers should treat this entity as a Medicare-centric provider when assessing reimbursement impact and network value.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

13 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,770	$690	$1.2M
J2777	Injection, faricimab‑svoa, 0.1 mg	27,300	$30	$791.7K
J2778	Injection, ranibizumab, 0.1 mg	1,250	$180	$230.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,700	$90	$156.6K
J3490	Unclassified drugs	60	$1,780	$101.6K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	480	$120	$57.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,650	$30	$54.5K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	520	$100	$52K
J3590	Unclassified biologics	20	$2,120	$31.8K
92250	Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,…	280	$30	$8.9K

Showing 1–10 of 13

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Jersey Distribution

Michael Colucciello — 1 of 13 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Jersey

Full comparison — all codes billed, vs. state median

13 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	13	90	880	$690	$693.6K
J2777	4	60	8,820	$30	$319K
J2778	16	40	1,140	$180	$240.8K
J3590	23	20	50	$2,180	$156.6K
67028	17	100	810	$100	$91.1K
J2781	11	20	570	$120	$88.8K
92014	260	1,130	160	$100	$34.9K
J3490	63	120	70	$230	$30.2K
99214	11,654	13,640	130	$90	$23.6K
92012	759	800	140	$70	$18.5K

Showing 1–10 of 13

Related Providers

Other providers that share a Tax Identification Number (TIN) with Michael Colucciello, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Associated Retinal Consultants LLC	DE	Ophthalmology Physician	$0	$25.2M
Rohit Lakhanpal	MD	Retina Specialist (Ophthalmology) Physician	$6.1M	$0
Vinod Voleti	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Sumit Shah	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Newman Sund	MD	Ophthalmology Physician	$4M	$0
Eric Suan	MD	Ophthalmology Physician	$3.8M	$0
Matthew Speicher	MD	Ophthalmology Physician	$3.7M	$0
Howard Fine	NJ	Retina Specialist (Ophthalmology) Physician	$3.6M	$0
Timothy Polk	MD	Ophthalmology Physician	$3.5M	$0
Jonathan Prenner	NJ	Retina Specialist (Ophthalmology) Physician	$3.4M	$0

Nearby Providers

Other providers in the same ZIP code as Michael Colucciello, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Vantage Surgical Associates, LLC	NJ	Ambulatory Surgical Clinic/Center	$1.6M	$14.1K
South Jersey Eye Physicians, LLC	NJ	Ambulatory Surgical Clinic/Center	$992.4K	$0
Sander Cohen	NJ	Ophthalmology Physician	$598.5K	$0
Ralph Russo	NJ	Nuclear Cardiology Physician	$458K	$0
Seth Berk	NJ	Hematology & Oncology Physician	$336.3K	$0
Nishith Gami	NJ	Internal Medicine Physician	$111.4K	$162.7K
Kathryn Stoedter	NJ	Foot & Ankle Surgery Podiatrist	$233K	$0
Patricia Zahner	NJ	Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician	$177.2K	$0
Qiujie Jiang	NJ	Dermatology Physician	$137K	$19.7K
James Sanfilippo	NJ	Orthopaedic Surgery of the Spine Physician	$130.2K	$0

Michael Colucciello — Billing Profile & Reimbursement Data

Sign up for Michael Colucciello — Billing Profile & Reimbursement Data policy alerts

Michael Colucciello — Billing Profile & Reimbursement Data

Sign up for Michael Colucciello — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References